APDN Reminds Shareholders to Vote Ahead of Special Meeting on February 14
February 11th, 2025
All Categories
ACDL
APDN in the News
CertainT®
Coronavirus
Corporate/Financial News
Investors
Large-Scale DNA Production
Linear DNA
mpox
PGx
Press Release
Uncategorized
Vaccines
Category: Investors
Applied DNA Reschedules Investor Update Call in Observance of the National Day of Mourning in Recognition of the Passing of Former President Jimmy Carter
January 8th, 2025
Applied DNA Announces Fourth Quarter and Fiscal Year 2024 Financial Results, Announces Strategic Restructuring to Prioritize the Manufacture of Critical Starting Materials for Genetic Medicines
December 17th, 2024
Applied DNA to Participate in the 2024 Maxim Healthcare Virtual Summit on Wednesday, October 16
October 15th, 2024
Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement
September 18th, 2024
Applied DNA Announces Third Quarter Fiscal Year 2024 Financial Results
August 8th, 2024
Applied DNA to Report Third Quarter Fiscal 2024 Financial Results on Thursday, August 8, 2024
August 7th, 2024
Applied DNA Announces Pricing of $12 Million Public Offering
May 28th, 2024
Applied DNA Announces Second Quarter Fiscal Year 2024 Financial Results
May 10th, 2024